...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of paediatrics and child health >Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand
【24h】

Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand

机译：新西兰风湿热和风湿性心脏病的死亡率和住院费用

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Aims: To estimate the annual mortality and the cost of hospital admissions for acute rheumatic fever (ARF) and rheumatic heart disease (RHD) for New Zealand residents. Methods: Hospital admissions in 2000-2009 with a principal diagnosis of ARF or RHD (ICD9-AM 390-398; ICD10-AM I00-I099) and deaths in 2000-2007 with RHD as the underlying cause were obtained from routine statistics. The cost of each admission was estimated by multiplying its diagnosis-related group (DRG) cost weight by the national price for financial year 2009/2010. Results: There were on average 159 RHD deaths each year with a mean annual mortality rate of 4.4 per 100 000 (95% confidence limit 4.2, 4.7). Age-adjusted mortality was five- to 10-fold higher for M?ori and Pacific peoples than for non-M?ori/Pacific. The mean age at RHD death (male/female) was 56.4/58.4 for M?ori, 50.9/59.8 for Pacific and 78.2/80.6 for non-M?ori, non-Pacific men and women. The average annual DRG-based cost of hospital admissions in 2000-2009 for ARF and RHD across all age groups was $12.0 million (95% confidence limit $11.1 million, $12.8 million). Heart valve surgery accounted for 28% of admissions and 71% of the cost. For children 5-14 years of age, valve surgery accounted for 7% of admissions and 27% of the cost. Two-thirds of the cost occurs after the age of 30. Conclusions: ARF and RHD comprise a burden of mortality and hospital cost concentrated largely in middle age. M?ori and Pacific RHD mortality rates are substantially higher than those of non-M?ori/Pacific.
机译：目的：估算新西兰居民的急性风湿热（ARF）和风湿性心脏病（RHD）的年死亡率和住院费用。方法：从常规统计中获得2000-2009年主要诊断为ARF或RHD（ICD9-AM 390-398; ICD10-AM I00-I099）的医院入院，以及2000-2007年以RHD为根本原因的死亡。通过将其诊断相关组（DRG）成本权重乘以2009/2010财政年度的国家价格，估算出每次入院的费用。结果：每年平均有159例RHD死亡，平均年死亡率为每10万人4.4（95％置信区间4.2，4.7）。毛利人和太平洋人的年龄调整死亡率比非毛利人/太平洋人高5至10倍。 RHD死亡的平均年龄（男性/女性）为：毛利人为56.4 / 58.4，太平洋地区为50.9 / 59.8，非毛利人，非太平洋地区的男性和女性为78.2 / 80.6。在2000-2009年间，所有年龄组的ARF和RHD的平均每年基于DRG的住院费用为1,200万美元（95％的置信限度为1,110万美元，1,280万美元）。心脏瓣膜手术占入院人数的28％，占费用的71％。对于5至14岁的儿童，瓣膜手术占入院人数的7％，占费用的27％。三分之二的费用发生在30岁以后。结论：ARF和RHD构成了死亡负担，医院费用主要集中在中年。毛利人和太平洋RHD死亡率大大高于非毛利人/太平洋地区。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号